If you think the idea of getting a transfusion with “young blood” to ward off aging sounds far-fetched, well, U.S. health officials agree.
Today (Feb. 19), the U.S. Food and Drug Administration (FDA) said it was concerned about reports of “bad actors” offering infusions of blood plasma from young people to purportedly treat age-related conditions and diseases, such a memory loss, Parkinson’s and Alzheimer’s disease. Such treatments are not only unproven, but they also come with potentially serious risks, the agency said.
Dispatches From The Front 